169 results on '"Geladari, Eleni"'
Search Results
2. Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension
3. Immunotherapy in Head and Neck Cancer: Where Do We Stand?
4. The influence of environmental factors on premature ovarian insufficiency and ovarian aging
5. Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives
6. FRI-076 Physical frailty diagnosed by short physical performance battery test is an independent poor prognostic factor of 360-day mortality in patients with liver cirrhosis
7. FRI-052 Anthropometric muscle mass indicators are effective in diagnosing muscle mass loss but are unable to diagnose myosteatosis, thus failing to identify all patients with sarcopenia in liver cirrhosis
8. Cardiac Troponin Levels in Patients with Chronic Kidney Disease: "Markers of High Risk or Just Noise"?
9. Evaluation of Five Screening Tools in Detecting Physical Frailty in Cirrhosis and Their Prognostic Role.
10. Diabetes type 1: Can it be treated as an autoimmune disorder?
11. NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics
12. Diabetes mellitus in the era of climate change
13. Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels
14. Benign Recurrent Intrahepatic Cholestasis: Where Are We Now?
15. Bilateral Subcutaneous Pitting Edema of the Upper Limbs as the Initial Sign of an Indolent Systemic Disease
16. Benign Recurrent Intrahepatic Cholestasis: Where are we now?
17. Bilateral Subcutaneous Pitting Edema of the Upper Limbs as the Initial Sign of an Indolent Systemic Disease
18. Beneficial effect of cystic fibrosis transmembrane conductance regulator modulators on adults with cystic fibrosis liver disease
19. The prevalence and prognostic impact of myosteatosis with and without sarcopenia and its association with age and severity of liver cirrhosis
20. Prevalence and predictors of HDV viremia in anti-HDV positive patients of the HEllenic multicenter ReAl-life CLInical Study (HERACLIS-HDV)
21. Structural Alterations in the Hypertensive Heart Disease Result in Intercalated Disc Remodeling and Arrhythmias
22. 'The Economic Burden of Hypertension'
23. ApoB100 and Atherosclerosis: What's New in the 21st Century?
24. Microbiome and hypertension: where are we now?
25. Pathways to Myocardial Hypertrophy
26. The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis
27. The Role of the Respiratory Microbiome in the Pathogenesis of Aspiration Pneumonia: Implications for Diagnosis and Potential Therapeutic Choices
28. Mechanisms of sarcopenia in liver cirrhosis and the role of myokines
29. Foods and Nutrients as Adjuvants in Cancer Chemo-prevention and Treatment
30. WED-362 - The prevalence and prognostic impact of myosteatosis with and without sarcopenia and its association with age and severity of liver cirrhosis
31. Role of the SHP2 Protein Tyrosine Phosphatase in Cardiac Metabolism
32. Myosteatosis is associated with sarcopenis, frailty and fat body composition abnormalities in liver corrhosis
33. "Failing kidneys in a failing planet; CKD of unknown origin".
34. Corrigendum to: Multifaceted Secukinumab-induced Colitis
35. “Failing kidneys in a failing planet; CKD of unknown origin”
36. Multifaceted Secukinumab-induced Colitis
37. Multiple mononeuritis with peripheral blood eosinophilia in a patient with Q fever: An unusual presentation: Case report and review of the literature
38. Cardiac MRI in Autoimmune Diseases: Where Are We Now?
39. Levetiracetam-associated Hypokalemia and Hypomagnesaemia among Two Patients Treated for Seizures
40. Pathways to Myocardial Hypertrophy
41. Bilateral Subcutaneous Pitting Edema of the Upper Limbs as the Initial Sign of an Indolent Systemic Disease
42. Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome
43. The effect of climate change on thermoregulation
44. WED-211 - Prevalence and predictors of HDV viremia in anti-HDV positive patients of the HEllenic multicenter ReAl-life CLInical Study (HERACLIS-HDV)
45. THU-298 - Beneficial effect of cystic fibrosis transmembrane conductance regulator modulators on adults with cystic fibrosis liver disease
46. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased?
47. Co-existence of Follicular Lymphoma in the Lymph Node with High-grade B Cell Lymphoma in the Bone Marrow of a Patient with Spontaneous Tumor Lysis Syndrome
48. Unexpected finding
49. Coexistence of Hodgkin and Non-Hodgkin Lymphoma; Composite Lymphoma [CL] in a Patient Presenting with Waxing and Waning Lymphadenopathy
50. Microbiome and hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.